BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37954598)

  • 21. Induction of Split Anergy Conditions Natural Killer Cells to Promote Differentiation of Stem Cells through Cell-Cell Contact and Secreted Factors.
    Tseng HC; Bui V; Man YG; Cacalano N; Jewett A
    Front Immunol; 2014; 5():269. PubMed ID: 24995006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver natural killer cell inoculum for liver transplantation with hepatocellular carcinoma.
    Nishida S; Levi DM; Tzakis AG
    Curr Opin Organ Transplant; 2013 Dec; 18(6):690-4. PubMed ID: 24220052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.
    Shi L; Lin H; Li G; Sun Y; Shen J; Xu J; Lin C; Yeh S; Cai X; Chang C
    Cancer Lett; 2016 Apr; 373(1):45-56. PubMed ID: 26805759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients.
    Chew V; Tow C; Huang C; Bard-Chapeau E; Copeland NG; Jenkins NA; Weber A; Lim KH; Toh HC; Heikenwalder M; Ng IO; Nardin A; Abastado JP
    J Natl Cancer Inst; 2012 Dec; 104(23):1796-807. PubMed ID: 23197495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
    Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
    Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting blockage of STAT3 in hepatocellular carcinoma cells augments NK cell functions via reverse hepatocellular carcinoma-induced immune suppression.
    Sun X; Sui Q; Zhang C; Tian Z; Zhang J
    Mol Cancer Ther; 2013 Dec; 12(12):2885-96. PubMed ID: 24107450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmented IFN-γ and TNF-α Induced by Probiotic Bacteria in NK Cells Mediate Differentiation of Stem-Like Tumors Leading to Inhibition of Tumor Growth and Reduction in Inflammatory Cytokine Release; Regulation by IL-10.
    Bui VT; Tseng HC; Kozlowska A; Maung PO; Kaur K; Topchyan P; Jewett A
    Front Immunol; 2015; 6():576. PubMed ID: 26697005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression.
    Shi L; Lin H; Li G; Jin RA; Xu J; Sun Y; Ma WL; Yeh S; Cai X; Chang C
    Mol Cancer Ther; 2016 Apr; 15(4):731-742. PubMed ID: 26939703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma.
    Lee HA; Goh HG; Lee YS; Jung YK; Kim JH; Yim HJ; Lee MG; An H; Jeen YT; Yeon JE; Byun KS; Seo YS
    BMC Gastroenterol; 2021 Jun; 21(1):258. PubMed ID: 34118869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity.
    Schmohl JU; Felices M; Oh F; Lenvik AJ; Lebeau AM; Panyam J; Miller JS; Vallera DA
    Cancer Res Treat; 2017 Oct; 49(4):1140-1152. PubMed ID: 28231426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Split anergized Natural Killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion.
    Tseng HC; Cacalano N; Jewett A
    Oncotarget; 2015 Apr; 6(11):8947-59. PubMed ID: 25860927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anterior gradient 2-derived peptide upregulates major histocompatibility complex class I-related chains A/B in hepatocellular carcinoma cells.
    Bian J; He L; Wu Y; Liu W; Ma H; Sun M; Yu J; Yu Z; Wei M
    Life Sci; 2020 Apr; 246():117396. PubMed ID: 32035130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probiotic-Treated Super-Charged NK Cells Efficiently Clear Poorly Differentiated Pancreatic Tumors in Hu-BLT Mice.
    Kaur K; Kozlowska AK; Topchyan P; Ko MW; Ohanian N; Chiang J; Cook J; Maung PO; Park SH; Cacalano N; Fang C; Jewett A
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31878338
    [No Abstract]   [Full Text] [Related]  

  • 34. Triptolide leads to hepatic intolerance to exogenous lipopolysaccharide and natural-killer-cell mediated hepatocellular damage by inhibiting MHC class I molecules.
    Zhang H; Yuan Z; Wang J; Tang Q; Miao Y; Yuan Z; Huang X; Zhu Y; Nong C; Zhang L; Jiang Z; Yu Q
    Phytomedicine; 2023 Jan; 109():154621. PubMed ID: 36610139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy.
    Han Y; Sun F; Zhang X; Wang T; Jiang J; Cai J; Gao Q; Hezam K; Liu Y; Xie J; Wang M; Zhang J
    J Cancer Res Clin Oncol; 2019 May; 145(5):1179-1190. PubMed ID: 30778749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma.
    Armeanu S; Krusch M; Baltz KM; Weiss TS; Smirnow I; Steinle A; Lauer UM; Bitzer M; Salih HR
    Clin Cancer Res; 2008 Jun; 14(11):3520-8. PubMed ID: 18519785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice.
    Qin WH; Yang ZS; Li M; Chen Y; Zhao XF; Qin YY; Song JQ; Wang BB; Yuan B; Cui XL; Shen F; He J; Bi YF; Ning G; Fu J; Wang HY
    Gastroenterology; 2020 May; 158(6):1713-1727. PubMed ID: 31972238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma.
    Nguyen T; Chen PC; Pham J; Kaur K; Raman SS; Jewett A; Chiang J
    Crit Rev Immunol; 2024; 44(5):71-85. PubMed ID: 38618730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.
    Yang X; Ye J; Yan H; Tang Z; Shen J; Zhang J; Yang L
    Tumour Biol; 2016 Jan; 37(1):201-9. PubMed ID: 26188902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.
    Su Z; Ye X; Shang L
    Yonsei Med J; 2019 Jan; 60(1):22-29. PubMed ID: 30554487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.